Ticker HubNasdaq

GALT

Galectin Therapeutics Inc.

PHARMACEUTICAL PREPARATIONS

Latest price

$3.26+2.19%

As of Oct 27, 2026, 11:00 AM EDT · Market data by Massive

Market cap

$321.7M

Volume

31.4K

Previous close

$3.19

Day range

$3.13 – $3.28

Listed

Sep 4, 2002

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $3.43Latest interval $3.26

Newsroom

Latest GALT coverage

SCD

BiotechNewsDec 21, 2018

Galectin Therapeutics Announces Extension of $10 Million Line Credit Nasdaq:GALT

NORCROSS, Ga., Dec. 20, 2018 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the main developer of therapeutics that focus on galectin proteins, as we speak introduced that its $10 million unsecured line of credit score entered into on December 19, 2017, has been prolonged by one yr for each borrowings and maturity. The line ...

GALT

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.